UC Irvine Health Affairs

Meet the interim vice chancellor

Alan Goldin, MD, PhD, is serving as interim vice chancellor of UC Irvine's Susan and Henry Samueli College of Health Sciences
UC Irvine Health Marketing & Communications
Alan Goldin, MD, PhD, has been named interim vice chancellor of the Susan and Henry Samueli College of Health Sciences at UC Irvine.

Alan L. Goldin, MD, PhD

Dr. Alan L. Goldin is the interim vice chancellor, Health Affairs, for the Susan and Henry Samueli College of Health Sciences at the University of California, Irvine.

Goldin is a professor of microbiology and molecular genetics, anatomy and neurobiology, and physiology and biophysics in the School of Medicine. He also directs the university’s Medical Scientist (MD/PhD) Training Program, which is funded by the National Institutes of Health (NIH).

Goldin also serves as the college’s associate vice chancellor for academic affairs and previously was the medical school’s senior associate dean for academic affairs.

Goldin received his bachelor’s degree in chemistry from Dartmouth College in 1976, followed by a joint MD and PhD in human genetics in 1983 from the University of Michigan’s Medical Scientist Training Program.

While working as a senior research fellow in biology at Caltech, he was awarded a National Multiple Sclerosis Society fellowship as well as a scholarship in biomedical sciences from the Lucille P. Markey Charitable Trust, after which he joined the UC Irvine faculty.

Goldin’s research focuses on how mutations in ion channel genes cause seizures and epilepsy, using mouse models to understand the effects of human mutations on the nervous system.

His research is funded by NIH, with previous support from the National Science Foundation (NSF), the McKnight Foundation, the American Heart Association, the March of Dimes and other foundations.

Goldin has served as a member of the NIH’s MDCN3 and the Biomedical Research and Research Training Study Sections, and on review panels for the Howard Hughes Medical Institute, the American Heart Association and the NSF.

He is currently a member of NIH’s Biophysical, Physiological, Pharmacological and Bioengineering Neuroscience Fellowship Study Section.